No description available.

No description available.

Thesis (M.S.)--Florida State University, 2006. / Advisor: Lisa Eckel, Florida State University, College of Arts and Sciences, Dept. of Psychology. Title and description from dissertation home page (viewed June 15, 2006). Document formatted into pages; contains vi, 34 pages. Includes bibliographical references.

No description available.

Spontaneous coronary artery dissection (SCAD) is a rare cause of acute coronary syndrome, cardiogenic shock, and sudden cardiac death in women of reproductive age who have no traditional risk factors for coronary artery disease. The etiology, prognosis, and treatment of SCAD remain poorly defined. Coronary angiography is the gold standard for diagnosis. Management includes medical therapy and revascularization procedures using percutaneous intervention and coronary artery bypass grafting. Possible mechanisms of SCAD include rupture of atherosclerotic plaque or vasa vasorum, hemorrhage between the outer media and external lamina with intramedial hematoma expansion, and compression of the vessel lumen. We report a case of SCAD in a 39-year-old woman presenting with ST-elevation myocardial infarction midway through her menstrual cycle. Her medications included fenfluramine for obesity and hydrochlorothiazide, amlodipine, and atenolol for hypertension.

Thesis (M.A.)--Trinity Graduate School, 2000. / Abstract. Includes bibliographical references (leaves 47-59).

Thesis (M.A.)--Trinity Graduate School, 2000. / Abstract. Includes bibliographical references (leaves 47-59).

Thesis (M.A.)--Trinity Graduate School, 2000. / Abstract. Includes bibliographical references (leaves 47-59).

Submitted by Fabio Sobreira Campos da Costa (fabio.sobreira@ufpe.br) on 2016-08-05T12:42:03Z No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) Tese final_Taisy.corrigida2016.biblioteca.pdf: 2862702 bytes, checksum: 4387dbfa9803b0de752dff7c0388521c (MD5) / Made available in DSpace on 2016-08-05T12:42:03Z (GMT). No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) Tese final_Taisy.corrigida2016.biblioteca.pdf: 2862702 bytes, checksum: 4387dbfa9803b0de752dff7c0388521c (MD5) Previous issue date: 2016-02-29 / CNPq / A maturação do sistema de controle de ingestão alimentar pode se moldar em correspondência ao ambiente nutricional, direcionando o seu padrão maduro. Nos primeiros dias de vida, no rato, o principal mediador para a saciedade e fome é a informação de enchimento ou esvaziamento gástrico, respectivamente. Esta informação nesse período é coordenada notadamente pela periferia provavelmente pela a imaturidade do controle central. O controle da ingestão alimentar homeostático é coordenado pelo núcleo do trato solitário e pelos núcleos hipotalâmicos que através de diferentes moléculas, como sensores energéticos, peptídeos e neurotransmissores coordena os sinais oriundos de tecidos periféricos. Portanto, os objetivos do presente trabalho foram avaliar a maturação de controle da ingestão alimentar em ratos neonatos e o papel do sistema serotoninérgico nesse processo. Foram utilizados ratos Wistar em duas idades P10 e P18 submetidos à desnutrição proteica ou não. Foram realizados os seguintes procedimentos experimentais: avaliação de ingestão alimentar, expressão gênica de peptídeos e sensores energéticos no hipotálamo de animais normonutridos e ativação de c-fos em resposta a agonista serotoninérgico no hipotálamo e núcleos da rafe em animais submetidos à desnutrição ou não. Nossos resultados revelaram que os sensores hipotalâmicos respondem precocemente ao estado de jejum (AMPKα1 -10dias: 16,79 ± 1,01, P=0,0174 e mTOR -10 dias: J=37,50 ± 2,67, p=0,036) e alimentado (AMPKα1 10dias: C=11,39 ± 1,17 e mTOR aos 10 dias: C=48,74 ± 4,21). A desnutrição promove inibição da via serotoninérgica além de reduzir a ativação de células imunorreativas aos 18 dias no núcleo PVN (Desnutrido-Fenfluramina: 200,8 ± 24,38, n=5, versus Desnutrido-Salina: 234,5 ± 43,32, n=5 p<0,006), traduzido em maior ganho de peso dos animais Desnutrido-Fenfluramina (2,32±0,36 n=10; p=0,017) em relação ao grupo Desnutrido-Salina (1,19±0,24 n=10). Portanto, nossos resultados revelam que o controle da ingestão alimentar em neonatos é afetado pela desnutrição com alterações na via serotoninérgica aos 18 dias e que os sinalizadores hipotalâmicos aos 10 dias participam sobre o controle da ingestão de alimentos. / The maturation of food intake patterns can be shaped in correspondence to the nutritional environment, directing his mature standard. In the first days of life in the rats, the main mediator for satiety and hunger is filling or gastric emptying, respectively.This information in this period is coordinated notably the periphery probably due to immaturity of the central control. The homeostatic control of food intake is coordinated by the nucleus of the solitary tract and the hypothalamic nuclei by different molecules, such as energy sensors, peptides and neurotransmitters coordinates signals from the periphery.Therefore, the objective of this study was to evaluate the control of maturation of food intake in newborn rats. Wistar rats were used at ages P10 and P18 submitted to protein malnutrition or not.The following experimental procedures were performed: assessment of food intake, gene expression of peptides and energy sensors in the hypothalamus of control animals and c-fos activation in response to agonist serotonin in the hypothalamus and raphe nuclei in animals subjected to malnutrition or not. Our results revealed that the hypothalamic sensors early answer to the fasting state (AMPKα1 10days: 16,79 ± 1,01 p = 0,0174) and mTOR at 10 days ( J = 37,50 ± 2,67; p = 0.036) and fed (AMPKα1 10days: C = 11,39 ± 1,17 and mTOR at 10 days: C = 48,74 ± 4,21). Malnutrition promotes inhibition of serotonin pathway and reduces the activation of immunoreactive cells after 18 days in the PVN core (Low protein-Fenfluramine: 200,8 ± 24,38; n = 5, versus Low protein-Salina: 234,5 ± 43,32; n = 5 p <0.006), translated into higher weight gain of Low protein-Fenfluramine animals (2,32 ± 0,36; n = 10; p = 0,017) compared to the group Low protein-Salina (1,19 ± 0,24, n = 10). Therefore, our results show that the control of food intake in newborns is affected by malnutrition to changes in serotonin via at 18 days and that the hypothalamic sensors at 10 days for the control of food intake.

Magister Pharmaceuticae - MPharm / The aim of this study was to investigate the mechanism of fenfluramine-induced pulmonary phospholipidosis, by comparing the profile and levels of induced phospholipids in the rat and the mode of phospholipase inactivation, both relative to that produced by chlorphentermine. Wistar and BD9 rats were injected with fenfluramine (FF) and chlorphentermine (CP) intra-peritoneally daily over a six week period to induce phospholipidosis. The lungs isolated from such treated and untreated animals, were grouped into unlavaged lungs and lungs to be lavaged and from the latter group the alveolar macrophages were isolated. Small sections of the unlavaged lungs were microscopically examined to verify the induction of phospholipidosis. Further the levels of phosphatidyl choline (PC), spingomyelin (SPM), phosphatidyl ethanolamine (PE), phosphatidyl glycerol (PG), phosphatidyl inositol (PI), phosphatidyl serine (PS) and phosphatidic acid (PA) were determined in both groups of lungs using a TLC method. To assess whether the drug-mediated inactivation of the phospholipases (PL) occurred via direct inhibition of the enzymes or via the drug-phospholipid complex, the hydrolysis of the above phospholipids by PL-A or PL-C were monitored using colorimetric methods. The feasibility of the phospholipid-drug complex-mediated mechanism was further explored, by assessing the effect the two drugs had on the phase transition temperature of the phospholipids. Electron microscopy revealed the presence of hypertrophied and elevated counts of alveolar macrophages in the treated-Wistar and -BD9 rats. In the FF- and CP treated Wistar and BD9 rats there were, compared to the saline-treated rats, a 200 % and 235 % increase in macrophage counts, respectively, for the FF-treated rats and a 700 % and 965 % increase in macrophage counts, respectively, for the CP treated rats. The levels of all the phospholipids in the unlavaged lungs of both rat strains were elevated, except that for PG, PS and PA. In both rat strains following the treatment with both drugs the PG levels were not elevated and the PS levels were not elevated following CP treatment. Following the treatment for both drugs, the PA levels were also not elevated in the BD9 rats. Relative to the levels found in the unlavaged lungs of the control rats, the increases ranged from a minimum of 9 to a maximum of 216 %. In general, Wistar rats appeared to be more susceptible to both FF and CP treatment. In both rat strains, lavaging of the lungs considerably reduced the levels of phospholipids remaining in the lung and the differences between the treated and untreated animals became less striking. The addition of FF or CP, whether directly to the enzyme, or in the form of the drug phospholipid complex, resulted in significant decreases in the PL-A-mediated or PL-C-mediated hydrolysis of virtualy all the test phospholipids. The average decrease ranged from 0.811 to 4.04 ,.,.FFAbbb ,.,.1-1sample min-I, for the PL-A activity and 0.023 to 0.827 ,.,.gIp'CC100 ,.,.1-1 sample min-I, for the PL-C activity. In the case of FF, the inhibition of PL-A activity could not be ascribed exclusively to either direct inhibition of the enzyme or reduced susceptibility of the phospholipid substrate-drug complex. The PL-C activity appeared to be inhibited to a greater extent via the phospholipid substrate-drug complex rather than by direct inhibition. On the other hand, CP induced a small, but significantly greater degree of inhibition of PL-A activity, more via direct inhibition, rather than by the phospholipid substrate-drug complex. The PL-C activity appeared to be inhibited to a greater extent via phospholipid substrate-drug complexation than by direct inhibition. From the above data, considered collectively, it was not possible to declare either of the two possible mechanisms as the more likely one for FF or CP-induced inhibition of the phospholipases. The feasibility of the indirect mode was further explored, by determining the phase transition temperatures for the phospholipid-drug complexes of each drug. The addition of each drug caused a depression of the phase transition temperature of all the phospholipids with a .1T'dd ranging from 0.52 to 15.73 °C. This appears to support the notion that both drugs bind to the phospholipids and the differences in the extent of the phase transition temperature depression of the individual phospholipids may indicate differences in the binding capacities of these drugs. The following major conclusions may be drawn from the results of this investigation. Fenfluramine induces a phospholipidosis syndrome in the lungs of Wistar and BD9 rats that are histologically similar to that induced by CP. It induces the elevation of essentially the same phospholipids as CP, primarily in the alveolar spaces and macrophages, and by implication, most likely via similar mechanisms. For both FF and CP, both direct inhibition and phospholipid-drug complex-mediated inhibition of phospholipases were found to be a viable mechanism for this syndrome. The mechanism for FF-induced pulmonary phospholipidosis thus appears to be similar to that of CP; small quantitative differences in essentially similar mechanisms, may explain the differences in the levels of induced phospholipidosis found in this study.